Patent Assignment
Reel/Frame 026125/0389
Assignment of Assignor's Interest
Recorded: 2011-04-14
Pages: 3
Assignor
AVENTIS PHARMA S.A.
Executed: 2003-05-20
Assignee
TARGACEPT, INC.
200 EAST FIRST STREET, SUITE 300, WINSTON-SALEM, NORTH CAROLINA, 27101
Covered Property
(1)
Arylvinylazacycloalkane Compounds and Methods of Preparation and Use Thereof
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 14, 2011
From: SCHMITT, JEFFREY DANIEL; DULL, GARY MAURICE
To: TARGACEPT, INC.
Reel/Frame 026125/0386 →
Assignment of Assignor's Interest
Apr 14, 2011
From: GENEVOIS-BORELLA, ARIELLE; CAPET, MARC; CHEVE, MICHEL
To: AVENTIS PHARMA S.A.
Reel/Frame 026125/0383 →
Change of Name
Jan 13, 2017
From: TARGACEPT, INC.
To: CATALYST BIOSCIENCES, INC.
Reel/Frame 041044/0211 →
Assignment of Assignor's Interest
Jan 13, 2017
From: CATALYST BIOSCIENCES, INC.
To: OYSTER POINT PHARMA, INC.
Reel/Frame 041043/0769 →
Patent Security Agreement
Aug 5, 2021
From: OYSTER POINT PHARMA, INC.
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
Reel/Frame 057104/0189 →
Corrective Assignment to Correct the the Conveying Party Execution Date Previously Recorded at Reel: 041044 Frame: 0211. Assignor(S) Hereby Confirms the Assignment.
Oct 26, 2021
From: TARGACEPT, INC.
To: CATALYST BIOSCIENCES, INC.
Reel/Frame 057923/0518 →
Release of Security Interest
Feb 3, 2023
From: ORBIMED ROYALTY & CREDIT OPPORTUNITIES III, LP
To: OYSTER POINT PHARMA INC.
Reel/Frame 062582/0873 →